Isabelle Archambeaud

2.6k total citations
18 papers, 322 citations indexed

About

Isabelle Archambeaud is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Isabelle Archambeaud has authored 18 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Isabelle Archambeaud's work include Liver Disease and Transplantation (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Isabelle Archambeaud is often cited by papers focused on Liver Disease and Transplantation (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Isabelle Archambeaud collaborates with scholars based in France, Spain and Japan. Isabelle Archambeaud's co-authors include Aurélie Plessier, Jérôme Gournay, Christophe Bureau, Jean Pierre Vinel, Patrick Borentain, Sophie Conchon, Nathalie Ganne‐Carrié, Vanessa Rousseau, Sébastien Dharancy and Nicolas Carbonell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Isabelle Archambeaud

18 papers receiving 318 citations

Peers

Isabelle Archambeaud

EPIDE

HEPAT

SURGE

ONCOL

IMMUN

Akiko Fujiwara Japan

Ömer Topalak Türkiye

Suut Göktürk Türkiye

Çağdaş Kalkan Türkiye

Loai Mansour Egypt

Ramazan Uçar Türkiye

Abdelrahman Kobtan Egypt

Mohamed I. Radwan Egypt

Kamal Chetri India

Hirotomo Harimoto Japan

Akiko Fujiwara Japan

Isabelle Archambeaud

144 ×0.8

EPIDE

124 ×0.7

HEPAT

71 ×0.5

SURGE

36 ×0.7

ONCOL

32 ×0.8

IMMUN

Citations per year, relative to Isabelle Archambeaud Isabelle Archambeaud (= 1×) peers Akiko Fujiwara

Countries citing papers authored by Isabelle Archambeaud

Since Specialization

Citations

This map shows the geographic impact of Isabelle Archambeaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Archambeaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Archambeaud more than expected).

Fields of papers citing papers by Isabelle Archambeaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Archambeaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Archambeaud. The network helps show where Isabelle Archambeaud may publish in the future.

Co-authorship network of co-authors of Isabelle Archambeaud

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Archambeaud. A scholar is included among the top collaborators of Isabelle Archambeaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Archambeaud. Isabelle Archambeaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Reig, María, Vincent C. Tam, Isabelle Archambeaud, et al.. (2024). 167P Non-viral aetiology subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC). Annals of Oncology. 35. S75–S76. 1 indexed citations

Lau, George, Bruno Sangro, Oxana Crysler, et al.. (2023). Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).. Journal of Clinical Oncology. 41(16_suppl). 4073–4073. 4 indexed citations

Garret, Charlotte, Arthur David, Morgane Péré, et al.. (2022). Infected pancreatic necrosis complicating severe acute pancreatitis in critically ill patients: predicting catheter drainage failure and need for necrosectomy. Annals of Intensive Care. 12(1). 71–71. 5 indexed citations

Quénéhervé, Lucille, et al.. (2021). Iatrogenic bilhemia after transjugular portal stent placement. Clinics and Research in Hepatology and Gastroenterology. 45(4). 101597–101597. 1 indexed citations

Bureau, Christophe, Dominique Thabut, Caroline Jézequel, et al.. (2021). The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Annals of Internal Medicine. 174(5). 633–640. 96 indexed citations

Touchefeu, Yann, Estelle Cauchin, Isabelle Archambeaud, et al.. (2020). Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability–High Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 19(4). e183–e188. 13 indexed citations

Goria, Odile, Isabelle Archambeaud, Aurélie Plessier, et al.. (2020). Ischemic cholangiopathy: An update. Clinics and Research in Hepatology and Gastroenterology. 44(4). 486–490. 9 indexed citations

Garret, Charlotte, Emmanuel Canet, Stéphane Corvec, et al.. (2020). Impact of prior antibiotics on infected pancreatic necrosis microbiology in ICU patients: a retrospective cohort study. Annals of Intensive Care. 10(1). 82–82. 11 indexed citations

Métairie, Sylvie, Christine Perret, Matthieu Schnee, et al.. (2019). Minilaparotomy-assisted transmesenteric approach for portal vein recanalization and transjugular intrahepatic portosystemic shunt in a non-cirrhotic patient with portal cavernoma. Diagnostic and Interventional Imaging. 101(6). 417–419. 2 indexed citations

10.

Bossard, Céline, et al.. (2019). Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature. SHILAP Revista de lepidopterología. 7(9). 1689–1693. 9 indexed citations

11.

Meyer, Jérémy, Isabelle Archambeaud, Jérôme Gournay, et al.. (2019). Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagnostic and Interventional Imaging. 100(7-8). 445–453. 8 indexed citations

12.

Garret, Charlotte, Jean Reignier, Aurélie Le Thuaut, et al.. (2018). Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitis. United European Gastroenterology Journal. 6(6). 910–918. 25 indexed citations

13.

Renand, Amédée, Jean‐François Mosnier, Nicolas Vince, et al.. (2018). Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment. Hepatology Communications. 2(8). 972–985. 43 indexed citations

14.

Sacher‐Huvelin, Sylvie, Paul Calès, Christophe Bureau, et al.. (2015). Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective study. Endoscopy. 47(6). 486–492. 20 indexed citations

15.

Graveleau, J., Marc Fouassier, Catherine Ternisien, et al.. (2014). Management of bleeding in severe factor V deficiency with a factor V inhibitor. Vox Sanguinis. 107(1). 97–99. 9 indexed citations

16.

Archambeaud, Isabelle, Pierre Nahon, Lucie Planche, et al.. (2014). Risk factors for hepatocellular carcinoma in Caucasian patients with non‐viral cirrhosis: the importance of prior obesity. Liver International. 35(7). 1872–1876. 21 indexed citations

17.

Touchefeu, Yann, Isabelle Archambeaud, Bruno Landi, et al.. (2013). Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer. Digestive and Liver Disease. 46(3). 283–286. 13 indexed citations

18.

Cany, Jeannette, Vanessa Gauttier, Isabelle Archambeaud, et al.. (2010). AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice. Journal of Hepatology. 54(1). 115–121. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact